SEC Filing Analysis: BECTON DICKINSON & CO (BDX)

Executive Summary

• Trading Significance: Low
• Key Takeaway: An executive sold a very small number of shares ($10.6K) as part of a pre-scheduled 10b5-1 trading plan, a routine event with no informational value.
• Market Impact: The transaction is immaterial and expected to have no impact on the stock's price or trading volume.

Company Information

Field	Value
Company	BECTON DICKINSON & CO
Ticker Symbol	BDX
CIK	0000010795
Industry	Surgical & Medical Instruments & Apparatus

Insider Information

Field	Value
Name	Feld Michael
CIK	0002034349
Title/Position	EVP & President, Life Sciences
Relationship	Officer

Transaction Details

Field	Value
Form Type	4
Transaction Date	2025-10-27
Transaction Code	S (Sale)
Security Type	Common Stock
Shares Involved	57
Price Per Share	$186.01
Total Value	$10,602.57
Shares Owned After	8,245
Ownership Type	Direct

Financial Impact Assessment

Transaction Materiality

Metric	Value
Transaction Value	$10,602.57
% of Market Cap	0.00002%
Shares Transacted	57
% of Shares Outstanding	0.00002%
Post-Transaction Ownership	8,245 shares (0.0029% of outstanding)
Materiality Assessment	Low

Impact Evaluation

• Market Cap Context: For a company with a market capitalization of $53.26 billion, a transaction of approximately $10,600 is financially insignificant and represents a rounding error in daily trading volume.
• Ownership Concentration: The insider's post-transaction ownership of 8,245 shares is a very small fraction (0.0029%) of the total shares outstanding, indicating low ownership concentration from this individual.
• Dilution Impact: Not applicable, as this was a sale of existing shares, not an issuance of new equity.
• Transaction Significance: The sale represents less than 0.7% of the insider's direct holdings, indicating it is not a significant liquidation of their position. The transaction's value and share count are far below any threshold for market significance.

Market Impact Analysis

Stock Impact Prediction

• Direction: Neutral
• Reasoning: The transaction is de minimis in size relative to the company's market cap and was executed under a 10b5-1 plan. Such sales are automatic and not timed based on material non-public information, thus they carry no predictive signal.

Volume & Sentiment

• Expected Volume Impact: None. The transaction size is too small to be noticeable in the stock's daily trading volume.
• Sentiment Indicator: Neutral. The market will correctly interpret this as a routine, non-event.

Investment Insights

Positive Market Indicators

• None can be derived from this filing.

Risk Factors

• None can be derived from this filing.

Key Takeaways

1. Immaterial Transaction: The sale of $10,602.57 worth of stock is insignificant for a $53.26 billion company.
2. Pre-Planned Sale: The transaction was conducted under a Rule 10b5-1 plan, removing any implication of the insider acting on recent information.
3. No Signal Value: This filing is a procedural disclosure and does not provide any bullish or bearish signals for investors.

Additional Context

Transaction Notes

• Special Circumstances: The filing explicitly notes this transaction was made pursuant to a Rule 10b5-1 plan adopted on February 7, 2025. This indicates a pre-scheduled, automated sale for purposes such as tax planning or portfolio diversification.